1. A Phase 3 Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of IV to Oral Omadacycline to Moxifloxacin for the Treatment of Adult Subjects with CABP (The OPTIC Study). (4th October 2017) Authors: Stets, Roman; Popescu, Monica; Gonong, Joven; Mitha, Ismail; Nseir, William; Madej, Andrzej; Kirsch, Courtney; Das, Anita; Garrity-Ryan, Lynne; Steenbergen, Judith N; Manley, Amy; Eckburg, Paul; Villano, Stephen; Tzanis, Evan; McGovern, Paul; Loh, Evan Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II, randomized, placebo‐controlled, double‐blind, multi‐dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. (July 2014) Authors: Baksi, Arun; Kraydashenko, Oleg; Zalevkaya, Alsu; Stets, Roman; Elliott, Peter; Haddad, Jonathan; Hoffmann, Ethan; Vlasuk, George P.; Jacobson, Eric W. Journal: British journal of clinical pharmacology Issue: Volume 78:Number 1(2014:Jul.) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗